ZICCUM

ziccum-logo

Ziccum is developing new dry-powder versions of the worldโ€™s most effective vaccines and biologic pharmaceuticals. These new, gently air-dried formulations can be transported easily and cost-effectively, with no costly cold storage or refrigeration required.

#SimilarOrganizations #People #Financial #Website #More

ZICCUM

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
2017-01-01

Address:
Lund, Skane Lan, Sweden

Country:
Sweden

Website Url:
http://www.ziccum.com

Total Employee:
1+

Status:
Active

Contact:
+46 709 61 55 99

Email Addresses:
[email protected]

Total Funding:
71.43 K EUR

Technology used in webpage:
HSTS Google Analytics 4 Person Schema Cloudflare JS CDN JS Gravatar Profiles ASP.NET IIS PostalAddress Schema IIS 10


Similar Organizations

cobra-biologics-logo

Cobra Biologics

Cobra Biologics is providing a biologics and pharmaceuticals service.

cristal-therapeutics-logo

Cristal Therapeutics

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.

cyteir-therapeutics-logo

Cyteir Therapeutics

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

kelsie-biotech-logo

KelSie Biotech

KelSie Biotech develops high bioavailability delivery methods to formulate and deliver sensitive active pharmaceutical ingredients.

meshlin-composites-logo

Meshlin Composites

Meshlin trying to preserve the natural character of the materials and are to assure versatility and long life of our products.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

terraplasma-logo

Terraplasma

Terraplasma offers solutions for the development of cold plasma products in areas where germs or unwanted odours lead to problems.

Current Employees Featured

goran-conradsson_image

Goran Conradsson
Goran Conradsson Founder & Chief Executive Officer (CEO) @ Ziccum
Founder & Chief Executive Officer (CEO)

michael-owens_image

Michael Owens
Michael Owens CFO @ Ziccum
CFO

Founder


goran-conradsson_image

Goran Conradsson

Investors List

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - Ziccum

Official Site Inspections

http://www.ziccum.com Semrush global rank: 11.11 M Semrush visits lastest month: 170

  • Host name: tama.oderland.com
  • IP address: 46.16.236.16
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Loading ...

More informations about "Ziccum"

About - Ziccum

Apr 5, 2017 Board Fredrik Sjövall Chairman Born: 1980 Appointed: April 5, 2017. Qualifications: M.Sc. Automation Engineering, Masterโ€™s Degree in Business Development. Independent of Ziccum and its senior management. โ€ฆSee details»

Ziccum successfully dries Biologics by Mass Transfer

Jan 8, 2025 Ziccum's unique drying and formulation system LaminarPace is a new way of drying biologics. It eliminates heat stress, heat degradation and the need for elevated temperatures. Unlike other pharmaceutical drying systems, โ€ฆSee details»

About us - Ziccum

Ziccum is developing LaminarPace®, a unique drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. โ€ฆSee details»

Ziccum - Crunchbase Company Profile & Funding

Ziccum focuses on drying mRNA/LNP, viral vectors using adenovirus, and subunit adjuvanted vaccines to improve their thermostability and administration routes. Novel Administration โ€ฆSee details»

Ziccum Company Profile - Office Locations, Competitors ... - Craft

Ziccum is a company providing a technology that transforms vaccines, drugs, biologics, and chemicals into dry powders that can be transported and don't need temperature control. The โ€ฆSee details»

Ziccum - Products, Competitors, Financials, Employees, โ€ฆ

Ziccum AB Mon, Nov 04, 2024 11:00 CET The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Ann Gidner will present Ziccum to โ€ฆSee details»

Ziccum Årsredovisning 2021

Den 1 december 2020 genomförde Ziccum ett listbyte till Nasdaq First North Growth Market. Bolagsinformation. Namn: Ziccum AB (publ) Organisationsnummer: 559107-9412. Juridisk โ€ฆSee details»

Ziccum Årsredovisning 2021

Ziccum utvecklar ett processteg i en ny produktionsmetod för biologiska läkemedel och vacciner. Bolagets affärsmodell bygger på att ingå strategiska samarbeten och licensavtal för att โ€ฆSee details»

Ziccum - VentureRadar

Ziccum is developing new dry-powder versions of the worldโ€™s most effective vaccines and biologic pharmaceuticals. These new, gently air-dried formulations can be transported easily and cost โ€ฆSee details»

Management team - Ziccum

May 9, 2022 Ziccum is developing LaminarPace®, a unique drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. By reducing drying stress to the active ingredient, LaminarPace® uniquely โ€ฆSee details»

Ziccum - ZICCUM AB - reports-en.ziccum.com

Ziccum has two main goals for 2021: to make concrete plans to establish a demonstration facility for Fill and Finish based on the LaminarPace technology, and to continue the work around out โ€ฆSee details»

Ziccum - ZICCUM AB - reports-en.ziccum.com

Ziccum's shares were listed on Spotlight Stock Markets on October 25, 2018. On December 1 2020, Ziccum moved to Nasdaq First North Growth Market. Market. Ziccum focuses on โ€ฆSee details»

Ziccum - ZICCUM AB - reports.ziccum.com

Användningsområdena för teknologin är dock många fler, och potentialen väsentligt större vid tillämpning inom andra applikationsområden. Av den anledningen genomförde Inhalation โ€ฆSee details»

Closing an intense year, building Ziccum to a new level (MFN)

Dec 23, 2024 The industry interest for Ziccumโ€™s technology is substantial and increasing. It is of great value to ensure that Ziccum and LaminarPace® can help making new and better patient โ€ฆSee details»

Investors - Ziccum

Ziccum is developing LaminarPace®, a unique drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. By reducing drying stress to the active โ€ฆSee details»

Ziccum - ZICCUM AB - reports-en.ziccum.com

Ziccum puts a lot of effort into developing the process of producing thermostable vaccines and adapting the technology for industrial production. This work is done with the aim of furthering โ€ฆSee details»

Ziccum Updates - Ziccum

Ziccum heads West in 2024 to J P Morgan Week & Longwood Healthcare Leaders CEO Conference Ziccum heads West in 2024, Jan 6 โ€“ 11, San Francisco. Book now to meet โ€ฆSee details»

VD-Intervju på svenska: Ziccums senaste avtal och den ... - Placera

Jun 26, 2024 Om Ziccum. Ziccum utvecklar LaminarPace, en unik metod för torkning av biologiska läkemedel och vacciner i rumstemperatur. Metoden bygger på massöverföring โ€ฆSee details»

Ziccum - ZICCUM AB - reports-en.ziccum.com

Ziccum Interim Report Q2 2021 Ziccum in short. Ziccum's patented technology LaminarPace air-dries liquid vaccine into a thermostable powder vaccine. Before it is administered, the vaccine โ€ฆSee details»

News and Press Releases - Ziccum

Jan 8, 2025 Ziccum is developing LaminarPace®, a unique drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. By reducing โ€ฆSee details»

linkstock.net © 2022. All rights reserved